Article info

Download PDFPDF

Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference

Authors

  • Donald Bastin Centre for Innovative Cancer ResearchOttawa Hospital Research Institute K1H 8L6 Ottawa Canada Department of Biochemistry, Microbiology and ImmunologyUniversity of Ottawa K1H 8M5 Ottawa Canada PubMed articlesGoogle scholar articles
  • Amelia S. Aitken Centre for Innovative Cancer ResearchOttawa Hospital Research Institute K1H 8L6 Ottawa Canada Department of Biochemistry, Microbiology and ImmunologyUniversity of Ottawa K1H 8M5 Ottawa Canada PubMed articlesGoogle scholar articles
  • Adrian Pelin Centre for Innovative Cancer ResearchOttawa Hospital Research Institute K1H 8L6 Ottawa Canada Department of Biochemistry, Microbiology and ImmunologyUniversity of Ottawa K1H 8M5 Ottawa Canada PubMed articlesGoogle scholar articles
  • Larissa A. Pikor Centre for Innovative Cancer ResearchOttawa Hospital Research Institute K1H 8L6 Ottawa Canada Department of Biochemistry, Microbiology and ImmunologyUniversity of Ottawa K1H 8M5 Ottawa Canada PubMed articlesGoogle scholar articles
  • Mathieu J. F. Crupi Centre for Innovative Cancer ResearchOttawa Hospital Research Institute K1H 8L6 Ottawa Canada Department of Biochemistry, Microbiology and ImmunologyUniversity of Ottawa K1H 8M5 Ottawa Canada PubMed articlesGoogle scholar articles
  • Michael S. Huh Centre for Innovative Cancer ResearchOttawa Hospital Research Institute K1H 8L6 Ottawa Canada Department of Biochemistry, Microbiology and ImmunologyUniversity of Ottawa K1H 8M5 Ottawa Canada PubMed articlesGoogle scholar articles
  • Marie-Claude Bourgeois-Daigneault Centre for Innovative Cancer ResearchOttawa Hospital Research Institute K1H 8L6 Ottawa Canada Department of Biochemistry, Microbiology and ImmunologyUniversity of Ottawa K1H 8M5 Ottawa Canada PubMed articlesGoogle scholar articles
  • John C. Bell Centre for Innovative Cancer ResearchOttawa Hospital Research Institute K1H 8L6 Ottawa Canada Department of Biochemistry, Microbiology and ImmunologyUniversity of Ottawa K1H 8M5 Ottawa Canada PubMed articlesGoogle scholar articles
  • Carolina S. Ilkow Centre for Innovative Cancer ResearchOttawa Hospital Research Institute K1H 8L6 Ottawa Canada Department of Biochemistry, Microbiology and ImmunologyUniversity of Ottawa K1H 8M5 Ottawa Canada PubMed articlesGoogle scholar articles
  1. i 613 737 8899 cilkow{at}uottawa.ca
View Full Text

Citation

Bastin D, Aitken AS, Pelin A, et al
Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference

Publication history

  • Received February 1, 2018
  • Accepted May 25, 2018
  • First published June 19, 2018.
Online issue publication 
February 10, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.